search
Back to results

Cerebellar Neuromodulation to Enhance Fear Extinction and Predict Response to Exposure Therapy

Primary Purpose

Anxiety Disorders, Social Phobia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Transcranial Direct Current Stimulation
Sponsored by
Laureate Institute for Brain Research, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Anxiety Disorders focused on measuring Social Phobia, Anxiety, Cerebellum, tDCS, Neuromodulation, Fear Extinction

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Generalize Anxiety or Social Phobia with an OASIS score =>8

Exclusion Criteria:

  • Safety concerns related to undergoing an fMRI scan or tDCS, such as metal in the head, history of unprovoked seizures in self or a first-degree family member, medications that reduce seizure threshold, pregnant or planning to become pregnant.
  • History of Post Traumatic Stress Disorder, Obsessive Compulsive Disorder, Panic Disorder, Current Major Depressive Illness, Substance Abuse in the past 1-year, or any thought disorder such as schizophrenia or bipolar disorder.

Sites / Locations

  • Laureate Institute for Brain Research

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Active Comparator

Arm Label

Anodal tDCS

Cathodal tDCS

Sham tDCS

Arm Description

Anodal tDCS will be performed over bilateral cerebellar hemispheres for 20-minutes.

Cathodal tDCS will be performed over bilateral cerebellar hemispheres for 20-minutes.

Sham tDCS will be performed over bilateral cerebellar hemispheres for 20-minutes.

Outcomes

Primary Outcome Measures

Activation of ventromedial prefrontal cortex after cerebellar stimulation
Activation of vmPFC

Secondary Outcome Measures

Change in resting state connectivity between vmPFC and cerebellar stimulation target
Change in resting state connectivity between vmPFC and cerebellum after cerebellar stimulation
Baseline cerebellar-cerebral connectivity prediction of exposure therapy outcomes
Baseline cerebellar-cerebral connectivity prediction of exposure therapy outcomes

Full Information

First Posted
September 5, 2017
Last Updated
August 28, 2020
Sponsor
Laureate Institute for Brain Research, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT03275337
Brief Title
Cerebellar Neuromodulation to Enhance Fear Extinction and Predict Response to Exposure Therapy
Official Title
Cerebellar Neuromodulation to Enhance Fear Extinction and Predict Response to Exposure Therapy
Study Type
Interventional

2. Study Status

Record Verification Date
August 2020
Overall Recruitment Status
Completed
Study Start Date
August 1, 2017 (Actual)
Primary Completion Date
December 31, 2019 (Actual)
Study Completion Date
December 31, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Laureate Institute for Brain Research, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Emerging neuroimaging studies have shown that the cerebellum contributes to different aspects of timing, prediction, learning, and extinction of conditioned responses to aversive stimuli, factors that may be relevant to the success of exposure based behavioral therapy. Our goals are to determine the cerebellar contributions to fear extinction by attempting to modulate key pathways in this process by theta burst stimulation. The long term goal is to lay the foundation for future studies in which neuromodulation is used to augment exposure therapy.
Detailed Description
Participants in this study will undergo an assessment for past history and present symptoms of mood, anxiety, trauma, substance abuse, and eating disorders. Safety screening for functional MRI (fMRI) and repetitive transcranial magnetic stimulation (rTMS) will be performed prior to enrollment. Phase 1 of the study involves two visits. The first visit involves undergoing an fMRI scan and a motor thresholding procedure for rTMS. A clinical assessment will be performed for the above symptoms, or a recap of symptoms if the participant had been previously assessed at our institute. The second visit involves a fear conditioning session performed in the fMRI scanner followed by one session of rTMS over either a cerebellar or occipital lobe (control) target. This will be immediately followed by a fear extinction phase, also in the fMRI scanner. The participant will return in 24hours to determine consolidation of the fear extinction process. Phase 2 is similar to Phase 1, except that each participant will undergo two sessions of the fear conditioning and fear extinction phases while undergoing an fMRI scan. In one session, they will receive rTMS over a cerebellar target. In the other session, they will receive rTMS over a control site. These sessions will be separated by at least 1 week. The participants will then undergo 10 weeks of exposure therapy for social phobia. The goal is to determine whether neuroplasticity related to cerebellar stimulation can predict the response to exposure therapy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anxiety Disorders, Social Phobia
Keywords
Social Phobia, Anxiety, Cerebellum, tDCS, Neuromodulation, Fear Extinction

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Anodal tDCS
Arm Type
Experimental
Arm Description
Anodal tDCS will be performed over bilateral cerebellar hemispheres for 20-minutes.
Arm Title
Cathodal tDCS
Arm Type
Experimental
Arm Description
Cathodal tDCS will be performed over bilateral cerebellar hemispheres for 20-minutes.
Arm Title
Sham tDCS
Arm Type
Active Comparator
Arm Description
Sham tDCS will be performed over bilateral cerebellar hemispheres for 20-minutes.
Intervention Type
Device
Intervention Name(s)
Transcranial Direct Current Stimulation
Other Intervention Name(s)
tDCS
Intervention Description
tDCS is a non-invasive form of neuromodulation in which direct current is administered placed over a brain region of interest to induce physiological changes such as inhibition or excitation over that region.
Primary Outcome Measure Information:
Title
Activation of ventromedial prefrontal cortex after cerebellar stimulation
Description
Activation of vmPFC
Time Frame
Phase 1, Years 1-3
Secondary Outcome Measure Information:
Title
Change in resting state connectivity between vmPFC and cerebellar stimulation target
Description
Change in resting state connectivity between vmPFC and cerebellum after cerebellar stimulation
Time Frame
Phase 1, Years 1-3
Title
Baseline cerebellar-cerebral connectivity prediction of exposure therapy outcomes
Description
Baseline cerebellar-cerebral connectivity prediction of exposure therapy outcomes
Time Frame
Phase 2, Years 3-5

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Generalize Anxiety or Social Phobia with an OASIS score =>8 Exclusion Criteria: Safety concerns related to undergoing an fMRI scan or tDCS, such as metal in the head, history of unprovoked seizures in self or a first-degree family member, medications that reduce seizure threshold, pregnant or planning to become pregnant. History of Post Traumatic Stress Disorder, Obsessive Compulsive Disorder, Panic Disorder, Current Major Depressive Illness, Substance Abuse in the past 1-year, or any thought disorder such as schizophrenia or bipolar disorder.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yoon-Hee Cha, MD
Organizational Affiliation
Laureate Institute for Brain Research
Official's Role
Principal Investigator
Facility Information:
Facility Name
Laureate Institute for Brain Research
City
Tulsa
State/Province
Oklahoma
ZIP/Postal Code
74011
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Cerebellar Neuromodulation to Enhance Fear Extinction and Predict Response to Exposure Therapy

We'll reach out to this number within 24 hrs